Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents.

× No keyword cloud information.

19 in total

1. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.

Authors: R Spanagel; A Herz; T S Shippenberg
Journal: Proc Natl Acad Sci U S A Date: 1992-03-15 Impact factor: 11.205

Review 2. Kappa opioid antagonists: past successes and future prospects.

Authors: Matthew D Metcalf; Andrew Coop
Journal: AAPS J Date: 2005-10-27 Impact factor: 4.009

3. 14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studies.

Authors: Guo Li; Lindsey C K Aschenbach; Hengjun He; Dana E Selley; Yan Zhang
Journal: Bioorg Med Chem Lett Date: 2008-12-29 Impact factor: 2.823

4. Aminothiazolomorphinans with mixed κ and μ opioid activity.

Authors: Tangzhi Zhang; Zhaohua Yan; Anna Sromek; Brian I Knapp; Thomas Scrimale; Jean M Bidlack; John L Neumeyer
Journal: J Med Chem Date: 2011-02-25 Impact factor: 7.446

5. Activation of Peripheral μ-opioid Receptors by Dermorphin [D-Arg2, Lys4] (1-4) Amide Leads to Modality-preferred Inhibition of Neuropathic Pain.

Authors: Vinod Tiwari; Fei Yang; Shao-Qiu He; Ronen Shechter; Chen Zhang; Bin Shu; Tong Zhang; Vineeta Tiwari; Yun Wang; Xinzhong Dong; Yun Guan; Srinivasa N Raja
Journal: Anesthesiology Date: 2016-03 Impact factor: 7.892

6. Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.

Authors: Yunyun Yuan; Guo Li; Hengjun He; David L Stevens; Patrick Kozak; Krista L Scoggins; Pallabi Mitra; Phillip M Gerk; Dana E Selley; William L Dewey; Yan Zhang
Journal: ACS Chem Neurosci Date: 2011-05-06 Impact factor: 4.418

7. Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mu opioid receptor selective antagonists.

Authors: Saheem A Zaidi; Christopher K Arnatt; Hengjun He; Dana E Selley; Philip D Mosier; Glen E Kellogg; Yan Zhang
Journal: Bioorg Med Chem Date: 2013-09-04 Impact factor: 3.641

8. The design and synthesis of a novel quinolizidine template for potent opioid and opioid receptor-like (ORL1, NOP) receptor ligands.

Authors: Ling Jong; Nurulain Zaveri; Lawrence Toll
Journal: Bioorg Med Chem Lett Date: 2004-01-05 Impact factor: 2.823

9. Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioids.

Authors: M Spetea; S T Nevin; S Hosztafi; A Z Rónai; G Tóth; A Borsodi
Journal: Neurochem Res Date: 1998-09 Impact factor: 3.996

10. Involvement of mu-opioid receptors in the modulation of pituitary-adrenal axis in normal and stressed rats.

Authors: E C degli Uberti; F Petraglia; M Bondanelli; A L Guo; A Valentini; S Salvadori; M Criscuolo; R E Nappi; A R Genazzani
Journal: J Endocrinol Invest Date: 1995-01 Impact factor: 4.256